Supporting the Fight Against COVID-19: Discounted Software Licenses for Clinical Research

For more than 20 years, Golden Helix has remained steadfast in our mission to empower precision medicine around the globe. Throughout this time, we’ve had the privilege of supporting clinicians, researchers, and healthcare professionals working at the forefront of genomic discovery and clinical diagnostics.

Now, as the world faces the unprecedented challenges brought on by the COVID-19 pandemic, we want to reaffirm our commitment to the community we serve. We understand the urgency and complexity of the work being done to better understand, track, and ultimately defeat this virus. As part of our continued support, we are offering significantly discounted 18-month software licenses to any organization conducting COVID-19-related research or clinical projects.

These licenses are available for all Golden Helix products and software bundles, and will be offered through May 15th, 2020. With this initiative, our goal is to provide long-term, reliable access to powerful analysis tools—without unexpected costs—so that your team can focus on the work that matters most. From variant interpretation to next-generation sequencing workflows, our platforms are built to support high-impact research and clinical decision-making.

We hope this offering enables more labs and institutions to continue their efforts uninterrupted. Whether you’re performing viral genome analysis, tracing mutations, or integrating COVID-19 data into larger population studies, we are here to help.

If your organization is working on COVID-19-related efforts, please contact our team before the deadline to discuss your goals and identify the right solution for your needs. You can also visit our dedicated page at bit.ly/covid19ghi for more information.

Thank you for everything you’re doing. Please stay safe and healthy.